Header Logo

SUSAN MARRIOTT

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Molecular Virology & Microbiology
AddressOne Baylor Plaza
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R21CA175404     (MARRIOTT, SUSAN J)Apr 1, 2013 - Mar 31, 2016
    NIH
    Development of a Novel Mouse Model to Evaluate HTLV Tax Transformation
    Role: Principal Investigator
    R21AI078307     (MARRIOTT, SUSAN J)Sep 25, 2008 - Aug 31, 2011
    NIH
    Transforming Potential of Emerging Human Retroviruses
    Role: Principal Investigator
    R01CA077371     (MARRIOTT, SUSAN J)Apr 1, 1999 - Feb 28, 2010
    NIH
    Mechanisms of Cellular Transformation by HTLV-1 TAX
    Role: Principal Investigator
    R01CA062921     (MARRIOTT, SUSAN J)Apr 15, 1994 - Mar 31, 1999
    NIH
    IMMUNE RESPONSE TO HTLV NONSTRUCTURAL PROTEINS
    Role: Principal Investigator
    R01CA055684     (MARRIOTT, SUSAN J)Feb 6, 1992 - Mar 31, 2008
    NIH
    Transcriptional Regulation of HTLV Gene Expression
    Role: Principal Investigator
    T32GM008231     (NELSON, DAVID LOREN)Jul 1, 1990 - Jun 30, 2020
    NIH
    Training Program in Cell and Molecular Biology
    Role: Co-Principal Investigator
    T32CA009197     (MARRIOTT, SUSAN J)Sep 15, 1979 - Jul 31, 2005
    NIH
    RESEARCH TRAINING PROGRAM IN VIRAL ONCOLOGY
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. . T-Cell Leukemia - Characteristics, Treatment and Prevention, ed. Tomita. Pleitropic functions of HTLV-1 Tax contribute to cellular transformation. 2013.
    2. Torti FM, Altieri D, Broach J, Fan H, Lotze M, Manfredi J, Matrisian L, Yu D, Giaccia A, Cancer Biology Training Consortium. Ph.D. Training in cancer biology. Cancer Res. 2008 Nov 15; 68(22):9122-4. PMID: 19010881.
      Citations: 4     Fields:    Translation:Humans
    3. . New Research on DNA Damage. Effects of the HTLV-1 viral oncoprotein, Tax, on cellular responses to DNA damage. 2008.
    4. MARRIOTT SJ. Viral Oncology: Basic Science and Clinical Perspectives, eds. Kuan Teh Jeang and Kamel Khalili. Oncogenic potential of HTLV-1 Tax Protein. 2008.
    5. . The Cancer Handbook, ed. Malcolm R. Alison. Human RNA Tumor Viruses. 2007; 123-132.
    6. . Viral Oncogenesis. ed. M Tognon. Transformation by human T-cell leukemia virus type-I. 2006; 183-202.
    7. Zhang SX, Garcia-Gras E, Wycuff DR, Marriot SJ, Kadeer N, Yu W, Olson EN, Garry DJ, Parmacek MS, Schwartz RJ. Identification of direct serum-response factor gene targets during Me2SO-induced P19 cardiac cell differentiation. J Biol Chem. 2005 May 13; 280(19):19115-26. PMID: 15699019.
      Citations: 44     Fields:    Translation:AnimalsCells
    8. . Progress in Retrovirus Research, S Thebault (ed). De-regulation of the cell cycle by human T cell leukemia virus type I (HTLV-I) Tax: mechanisms and effects. 2005; 39-63.
    9. Mercier S, Bounou S, Marriot SJ, Barbeau B, Tremblay MJ, Dumais N, Par? ME. T-cell receptor/CD28 engagement when combined with prostaglandin E2 treatment leads to potent activation of human T-cell leukemia virus type 1. J Virol. 2003 Oct; 77(20):11170-9. PMID: 14512564; PMCID: PMC224985.
      Citations: 9     Fields:    Translation:HumansCells
    10. . Modular control of HTLV-I transcription: A story of cooperation and competition. Current Topics in Virology. 2003; (3):109-117.
    11. Kao SY, Lemoine FJ, Mariott SJ. HTLV-1 Tax protein sensitizes cells to apoptotic cell death induced by DNA damaging agents. Oncogene. 2000 Apr 27; 19(18):2240-8. PMID: 10822374.
      Citations: 18     Fields:    Translation:AnimalsCells
    12. . Effect of human T cell leukemia virus type I (HTLV-I) on genome stability: implications in the progression of adult T cell leukemia. Research Advances in Virology. 2000; (1):1-12.
    13. MARRIOTT SJ, PL Lindholm, S Gitlin, KM Brown, MF Radonovich, JF Duvall, and JN Brady. . Early Human Retroviruses, UCLA Symposia on Molecular and Cellular Biology. JE Groopman, ISY Chen, M Essex and R Weiss (eds),. Molecular analysis of trans-activation in the HTLV-I LTR. 1989; (119):13-22.
    14. . Virus Attachment and Entry into Cells, RL Crowell and K Lonberg-Holm (ed). Biochemical characterization of the polyoma-receptor interaction. 1986; 44-53.
    15. MARRIOTT SJ. Handbook of Neurovirology, RR McKendall and WG Stroop (eds). Human T-lymphotropic virus-I (HTLV-I).
    MARRIOTT's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (72)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _